Summit Therapeutics Cash Flow Statement (2014-2026) | SMMT

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jan2014 Apr2014 Jul2014 Oct2014 Jan2015 Apr2015 Jul2015 Oct2015 Jan2016 Apr2016 Jul2016 Oct2016 Jan2017 Apr2017 Jul2017 Oct2017 Dec2017 Jan2018 Apr2018 Jul2018 Oct2018 Jan2019 Mar2019 Apr2019 Jul2019 Sep2019 Oct2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-24.42M-19.60M-27.10M-22.16M-12.69M-16.94M-20.30M-537.15M-15.79M-20.49M-36.21M-45.51M-62.72M-60.83M-65.62M
Depreciation and Depletion (Quarter)
0.09M0.08M0.08M0.07M0.10M0.09M0.09M0.09M0.05M0.03M0.03M0.03M0.02M0.02M0.02M0.03M0.04M0.04M0.04M0.04M
Share-based Compensation (Quarter)
3.67M2.64M5.62M4.00M2.50M2.80M2.66M2.77M1.88M0.70M8.75M9.51M11.09M19.37M11.02M11.10M478.78M130.76M111.78M72.79M
Deferred Taxes (Quarter)
Cash from Discontinued Operations (Quarter)
Gains from Investment Securities (Quarter)
-1.08M1.26M2.76M-2.76M4.25M-2.45M6.66M1.42M2.25M-2.86M16.24M1.03M
Asset Writedowns and Impairment (Quarter)
8.47M0.47M
Non-cash Items (Quarter)
Cash from Operations (Quarter)
-19.17M-23.57M-9.18M-19.00M-19.22M-8.55M5.19M-13.13M-29.27M-14.90M-19.46M-30.13M-33.00M-30.30M-48.67M-61.17M-66.74M-93.08M-101.94M-122.29M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.26M0.26M0.34M0.30M0.23M0.22M-0.96M0.21M0.40M1.60M2.92M-2.35M2.97M1.02M3.02M4.22M
Amortization (Quarter)
Depreciation & Amortization (CF) (Quarter)
0.09M0.08M0.08M0.07M0.10M0.09M0.09M0.09M0.05M0.03M0.03M0.03M0.02M0.02M0.02M0.03M0.04M0.04M0.04M0.04M
Change in Working Capital
Change in Receivables (Quarter)
0.59M1.37M-0.93M-0.46M-0.70M-1.23M1.41M-0.35M-0.01M-0.00M
Change in Account Payables (Quarter)
2.75M-1.02M-1.36M2.76M-3.48M-1.04M-2.37M0.31M0.30M2.33M-0.67M3.70M-3.04M-0.18M1.53M0.36M17.93M-0.84M-2.15M6.80M
Change in Accured Expenses (Quarter)
3.59M-0.42M-0.16M-3.52M2.44M5.89M-0.04M-3.24M1.10M-5.59M5.35M-2.23M2.32M0.20M6.26M1.61M4.84M0.94M-4.49M-1.14M
Change in Taxes (Quarter)
Other Working Capital Changes (Quarter)
-3.82M2.63M-1.01M-0.30M-0.93M-3.77M5.01M-0.51M0.51M3.55M-7.17M1.74M-2.79M0.09M-1.51M-1.85M1.90M-3.71M8.53M-0.03M
Investing Activities
Capital Expenditures (Quarter)
0.15M-0.00M0.12M0.36M0.29M-0.02M-0.01M0.05M0.02M0.05M0.00M0.00M0.06M-0.07M0.14M0.42M-0.35M0.42M0.16M0.75M
Change in Intangibles (Quarter)
Change in Acquisitions & Divestments (Quarter)
38.17M109.42M60.57M112.86M70.00M74.00M232.98M160.53M150.81M177.29M
Cash from Investing Activities (Quarter)
-0.15M0.00M-0.12M-0.36M-0.29M0.02M0.01M-645.06M0.21M-3.49M60.57M19.87M-200.08M-108.61M83.48M160.11M150.81M-0.07M-485.16M-0.24M
Financing Activities
Other financing activities (Quarter)
0.10M-0.04M0.11M0.54M0.08M1.19M
Cash from Financing Activities (Quarter)
20.08M0.68M1.26M25.19M75.00M520.06M80.11M-0.08M0.23M6.25M0.48M200.21M204.14M-23.61M7.68M2.22M33.81M573.82M3.80M
Additional items
Exchange Rate Effect (Quarter)
0.43M-0.25M-0.42M-0.17M-0.60M-1.83M1.38M0.44M0.29M-0.17M0.27M-0.04M0.01M0.11M-0.11M0.04M0.06M0.02M-0.02M-0.02M
Change in Cash (Quarter)
1.19M-23.14M-8.46M5.66M-20.11M64.64M526.64M-577.64M-28.85M-18.32M47.63M-9.81M-32.86M65.34M11.09M106.66M86.35M-59.32M-13.29M-118.75M
Beginning Cash Balance (Quarter)
25.00M24.69M75.50M75.50M
Free Cash Flow (Quarter)
-19.32M-23.56M-9.30M-19.36M-19.51M-8.54M5.20M-13.18M-29.29M-14.95M-19.46M-30.14M-33.06M-30.23M-48.81M-61.59M-66.39M-93.50M-102.10M-123.04M
Net Cash Flow (Quarter)
0.76M-22.89M-8.04M5.83M-19.51M66.46M525.26M-578.08M-29.15M-18.15M47.36M-9.78M-32.87M65.23M11.20M106.62M86.29M-59.34M-13.27M-118.73M